Company facts
- Headquarters
- Monrovia, California
- Most recent report
- 8-K, filed Oct 9, 2026
- Incorporated
- Nevada
- Filings on record
- 120 filings
- On EDGAR
- CIK 2010788
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8
News 8 of 22
Prospectuses and Registrations 8 of 25
- 424B5 Prospectus supplement for an offering Jun 30, 2026
- 424B5 Prospectus supplement for an offering Jun 8, 2026
- 424B5 Prospectus supplement for an offering Jun 4, 2026
- 424B5 Prospectus supplement for an offering May 29, 2026
- 424B5 Prospectus supplement for an offering Apr 9, 2026
- 424B2 Prospectus supplement for an offering Jan 26, 2026
- S-3 Shelf registration statement Jan 16, 2026
- S-8 Registration statement for an employee plan Dec 16, 2025
Proxies 4
Ownership 8 of 36
- 4 Insider reported a trade Sep 17, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Apr 10, 2026
- 4 Insider reported a trade Apr 8, 2026
- 3 Insider reported their initial holding Apr 8, 2026
- 4 Insider reported a trade Apr 8, 2026
Other 8 of 25
- EFFECT Notice that a registration became effective Jan 23, 2026
- CORRESP Reply to SEC staff Jan 22, 2026
- DRS Draft registration statement, submitted confidentially Dec 15, 2025
- D Nov 19, 2024
- CERT Exchange certified a listing Nov 12, 2024
- EFFECT Notice that a registration became effective Nov 8, 2024
- CORRESP Reply to SEC staff Nov 6, 2024
- CORRESP Reply to SEC staff Nov 6, 2024
Everything here comes from Exozymes Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.